nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1A1—polycystic ovary syndrome	0.581	1	CbGaD
Lansoprazole—Tonsillitis—Metformin—polycystic ovary syndrome	0.00942	0.0781	CcSEcCtD
Lansoprazole—Abnormal faeces—Metformin—polycystic ovary syndrome	0.00833	0.069	CcSEcCtD
Lansoprazole—ATP4B—endocrine gland—polycystic ovary syndrome	0.0064	0.0638	CbGeAlD
Lansoprazole—CYP2C19—urine—polycystic ovary syndrome	0.00586	0.0585	CbGeAlD
Lansoprazole—MAPT—pituitary gland—polycystic ovary syndrome	0.00484	0.0482	CbGeAlD
Lansoprazole—MAPT—adipose tissue—polycystic ovary syndrome	0.00482	0.048	CbGeAlD
Lansoprazole—CYP1A2—urine—polycystic ovary syndrome	0.00479	0.0477	CbGeAlD
Lansoprazole—CYP2C9—urine—polycystic ovary syndrome	0.00455	0.0453	CbGeAlD
Lansoprazole—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.00453	0.0375	CcSEcCtD
Lansoprazole—ATP4A—adrenal cortex—polycystic ovary syndrome	0.00445	0.0443	CbGeAlD
Lansoprazole—MAPT—adrenal gland—polycystic ovary syndrome	0.00432	0.0431	CbGeAlD
Lansoprazole—Thiabendazole—CYP1A1—polycystic ovary syndrome	0.0042	0.445	CrCbGaD
Lansoprazole—CYP4A11—vagina—polycystic ovary syndrome	0.00369	0.0368	CbGeAlD
Lansoprazole—Nail disorder—Metformin—polycystic ovary syndrome	0.00367	0.0304	CcSEcCtD
Lansoprazole—CYP3A4—urine—polycystic ovary syndrome	0.00347	0.0346	CbGeAlD
Lansoprazole—CYP4A11—endocrine gland—polycystic ovary syndrome	0.00345	0.0344	CbGeAlD
Lansoprazole—CYP2D6—urine—polycystic ovary syndrome	0.00341	0.034	CbGeAlD
Lansoprazole—ATP4A—adrenal gland—polycystic ovary syndrome	0.00321	0.032	CbGeAlD
Lansoprazole—Blood disorder—Metformin—polycystic ovary syndrome	0.00285	0.0236	CcSEcCtD
Lansoprazole—Omeprazole—CYP11A1—polycystic ovary syndrome	0.00283	0.3	CrCbGaD
Lansoprazole—ATP4A—endocrine gland—polycystic ovary syndrome	0.00278	0.0277	CbGeAlD
Lansoprazole—Contusion—Metformin—polycystic ovary syndrome	0.00273	0.0226	CcSEcCtD
Lansoprazole—Accidental injury—Metformin—polycystic ovary syndrome	0.00269	0.0223	CcSEcCtD
Lansoprazole—CYP2C18—vagina—polycystic ovary syndrome	0.00245	0.0244	CbGeAlD
Lansoprazole—CYP2C18—endocrine gland—polycystic ovary syndrome	0.00229	0.0228	CbGeAlD
Lansoprazole—Neuropathy—Metformin—polycystic ovary syndrome	0.00223	0.0185	CcSEcCtD
Lansoprazole—Ear pain—Metformin—polycystic ovary syndrome	0.00203	0.0168	CcSEcCtD
Lansoprazole—Injury—Metformin—polycystic ovary syndrome	0.00188	0.0156	CcSEcCtD
Lansoprazole—Renal impairment—Metformin—polycystic ovary syndrome	0.00182	0.015	CcSEcCtD
Lansoprazole—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00177	0.0147	CcSEcCtD
Lansoprazole—Migraine—Metformin—polycystic ovary syndrome	0.0017	0.0141	CcSEcCtD
Lansoprazole—Dehydration—Metformin—polycystic ovary syndrome	0.00161	0.0133	CcSEcCtD
Lansoprazole—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0016	0.0132	CcSEcCtD
Lansoprazole—Breast disorder—Metformin—polycystic ovary syndrome	0.00156	0.0129	CcSEcCtD
Lansoprazole—Cramp muscle—Metformin—polycystic ovary syndrome	0.00156	0.0129	CcSEcCtD
Lansoprazole—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00155	0.0128	CcSEcCtD
Lansoprazole—Abdominal distension—Metformin—polycystic ovary syndrome	0.0015	0.0125	CcSEcCtD
Lansoprazole—Influenza—Metformin—polycystic ovary syndrome	0.00149	0.0124	CcSEcCtD
Lansoprazole—Pancreatitis—Metformin—polycystic ovary syndrome	0.00146	0.0121	CcSEcCtD
Lansoprazole—CYP1B1—uterus—polycystic ovary syndrome	0.00146	0.0145	CbGeAlD
Lansoprazole—Angina pectoris—Metformin—polycystic ovary syndrome	0.00145	0.0121	CcSEcCtD
Lansoprazole—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00143	0.0119	CcSEcCtD
Lansoprazole—CYP1B1—pituitary gland—polycystic ovary syndrome	0.00143	0.0143	CbGeAlD
Lansoprazole—CYP1B1—adipose tissue—polycystic ovary syndrome	0.00142	0.0142	CbGeAlD
Lansoprazole—Neutropenia—Metformin—polycystic ovary syndrome	0.0014	0.0116	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00139	0.0115	CcSEcCtD
Lansoprazole—Infestation NOS—Metformin—polycystic ovary syndrome	0.00133	0.011	CcSEcCtD
Lansoprazole—Infestation—Metformin—polycystic ovary syndrome	0.00133	0.011	CcSEcCtD
Lansoprazole—Rabeprazole—CYP1A1—polycystic ovary syndrome	0.00132	0.14	CrCbGaD
Lansoprazole—ABCG2—adrenal cortex—polycystic ovary syndrome	0.00132	0.0131	CbGeAlD
Lansoprazole—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00131	0.0108	CcSEcCtD
Lansoprazole—CYP1B1—adrenal gland—polycystic ovary syndrome	0.00128	0.0127	CbGeAlD
Lansoprazole—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00126	0.0104	CcSEcCtD
Lansoprazole—Bradycardia—Metformin—polycystic ovary syndrome	0.00122	0.0101	CcSEcCtD
Lansoprazole—CYP2C8—endometrium—polycystic ovary syndrome	0.00121	0.0121	CbGeAlD
Lansoprazole—Rhinitis—Metformin—polycystic ovary syndrome	0.0012	0.00993	CcSEcCtD
Lansoprazole—Hepatitis—Metformin—polycystic ovary syndrome	0.0012	0.00991	CcSEcCtD
Lansoprazole—CYP1B1—female gonad—polycystic ovary syndrome	0.00119	0.0119	CbGeAlD
Lansoprazole—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00119	0.00986	CcSEcCtD
Lansoprazole—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00118	0.00976	CcSEcCtD
Lansoprazole—ABCG2—endometrium—polycystic ovary syndrome	0.00118	0.0117	CbGeAlD
Lansoprazole—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00117	0.00974	CcSEcCtD
Lansoprazole—Eye disorder—Metformin—polycystic ovary syndrome	0.00112	0.00926	CcSEcCtD
Lansoprazole—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00111	0.0092	CcSEcCtD
Lansoprazole—CYP1B1—endocrine gland—polycystic ovary syndrome	0.00111	0.011	CbGeAlD
Lansoprazole—CYP2C8—pituitary gland—polycystic ovary syndrome	0.0011	0.0109	CbGeAlD
Lansoprazole—ABCG2—uterus—polycystic ovary syndrome	0.00108	0.0108	CbGeAlD
Lansoprazole—Angiopathy—Metformin—polycystic ovary syndrome	0.00108	0.00899	CcSEcCtD
Lansoprazole—Immune system disorder—Metformin—polycystic ovary syndrome	0.00108	0.00895	CcSEcCtD
Lansoprazole—Omeprazole—CYP1A1—polycystic ovary syndrome	0.00108	0.114	CrCbGaD
Lansoprazole—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00108	0.00893	CcSEcCtD
Lansoprazole—Chills—Metformin—polycystic ovary syndrome	0.00107	0.00889	CcSEcCtD
Lansoprazole—ABCG2—pituitary gland—polycystic ovary syndrome	0.00107	0.0106	CbGeAlD
Lansoprazole—ABCG2—adipose tissue—polycystic ovary syndrome	0.00106	0.0106	CbGeAlD
Lansoprazole—Erythema—Metformin—polycystic ovary syndrome	0.00104	0.00862	CcSEcCtD
Lansoprazole—Malnutrition—Metformin—polycystic ovary syndrome	0.00104	0.00862	CcSEcCtD
Lansoprazole—CYP2C19—vagina—polycystic ovary syndrome	0.00104	0.0104	CbGeAlD
Lansoprazole—CYP1A1—uterus—polycystic ovary syndrome	0.00103	0.0103	CbGeAlD
Lansoprazole—Flatulence—Metformin—polycystic ovary syndrome	0.00103	0.0085	CcSEcCtD
Lansoprazole—Dysgeusia—Metformin—polycystic ovary syndrome	0.00102	0.00845	CcSEcCtD
Lansoprazole—CYP1A1—adipose tissue—polycystic ovary syndrome	0.00101	0.01	CbGeAlD
Lansoprazole—Muscle spasms—Metformin—polycystic ovary syndrome	0.001	0.00829	CcSEcCtD
Lansoprazole—Vision blurred—Metformin—polycystic ovary syndrome	0.000981	0.00813	CcSEcCtD
Lansoprazole—Tremor—Metformin—polycystic ovary syndrome	0.000975	0.00808	CcSEcCtD
Lansoprazole—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000973	0.00969	CbGeAlD
Lansoprazole—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000965	0.008	CcSEcCtD
Lansoprazole—ABCG2—adrenal gland—polycystic ovary syndrome	0.000952	0.00949	CbGeAlD
Lansoprazole—Malaise—Metformin—polycystic ovary syndrome	0.000938	0.00778	CcSEcCtD
Lansoprazole—Syncope—Metformin—polycystic ovary syndrome	0.000933	0.00773	CcSEcCtD
Lansoprazole—Palpitations—Metformin—polycystic ovary syndrome	0.00092	0.00762	CcSEcCtD
Lansoprazole—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000915	0.00758	CcSEcCtD
Lansoprazole—CYP2C8—vagina—polycystic ovary syndrome	0.000907	0.00904	CbGeAlD
Lansoprazole—Hypertension—Metformin—polycystic ovary syndrome	0.000898	0.00745	CcSEcCtD
Lansoprazole—ABCG2—female gonad—polycystic ovary syndrome	0.000887	0.00885	CbGeAlD
Lansoprazole—Myalgia—Metformin—polycystic ovary syndrome	0.000886	0.00734	CcSEcCtD
Lansoprazole—Chest pain—Metformin—polycystic ovary syndrome	0.000886	0.00734	CcSEcCtD
Lansoprazole—ABCG2—vagina—polycystic ovary syndrome	0.000882	0.00879	CbGeAlD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00088	0.00729	CcSEcCtD
Lansoprazole—Discomfort—Metformin—polycystic ovary syndrome	0.000875	0.00725	CcSEcCtD
Lansoprazole—Oedema—Metformin—polycystic ovary syndrome	0.000849	0.00704	CcSEcCtD
Lansoprazole—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000849	0.00846	CbGeAlD
Lansoprazole—Infection—Metformin—polycystic ovary syndrome	0.000844	0.00699	CcSEcCtD
Lansoprazole—CYP1A1—female gonad—polycystic ovary syndrome	0.000842	0.0084	CbGeAlD
Lansoprazole—CYP1A1—vagina—polycystic ovary syndrome	0.000837	0.00835	CbGeAlD
Lansoprazole—Shock—Metformin—polycystic ovary syndrome	0.000835	0.00693	CcSEcCtD
Lansoprazole—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000833	0.0069	CcSEcCtD
Lansoprazole—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000831	0.00689	CcSEcCtD
Lansoprazole—Skin disorder—Metformin—polycystic ovary syndrome	0.000825	0.00684	CcSEcCtD
Lansoprazole—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000821	0.0068	CcSEcCtD
Lansoprazole—Anorexia—Metformin—polycystic ovary syndrome	0.000809	0.00671	CcSEcCtD
Lansoprazole—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000794	0.00792	CbGeAlD
Lansoprazole—Hypotension—Metformin—polycystic ovary syndrome	0.000794	0.00658	CcSEcCtD
Lansoprazole—ABCB1—embryo—polycystic ovary syndrome	0.000793	0.00791	CbGeAlD
Lansoprazole—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000784	0.00781	CbGeAlD
Lansoprazole—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000774	0.00641	CcSEcCtD
Lansoprazole—Paraesthesia—Metformin—polycystic ovary syndrome	0.000763	0.00632	CcSEcCtD
Lansoprazole—Dyspnoea—Metformin—polycystic ovary syndrome	0.000757	0.00628	CcSEcCtD
Lansoprazole—Somnolence—Metformin—polycystic ovary syndrome	0.000755	0.00626	CcSEcCtD
Lansoprazole—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000754	0.00752	CbGeAlD
Lansoprazole—Dyspepsia—Metformin—polycystic ovary syndrome	0.000748	0.0062	CcSEcCtD
Lansoprazole—Decreased appetite—Metformin—polycystic ovary syndrome	0.000738	0.00612	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000733	0.00608	CcSEcCtD
Lansoprazole—Fatigue—Metformin—polycystic ovary syndrome	0.000732	0.00607	CcSEcCtD
Lansoprazole—Constipation—Metformin—polycystic ovary syndrome	0.000726	0.00602	CcSEcCtD
Lansoprazole—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0007	0.0058	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000694	0.00576	CcSEcCtD
Lansoprazole—Urticaria—Metformin—polycystic ovary syndrome	0.000675	0.00559	CcSEcCtD
Lansoprazole—Abdominal pain—Metformin—polycystic ovary syndrome	0.000671	0.00556	CcSEcCtD
Lansoprazole—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00065	0.00648	CbGeAlD
Lansoprazole—Asthenia—Metformin—polycystic ovary syndrome	0.000609	0.00505	CcSEcCtD
Lansoprazole—CYP2D6—female gonad—polycystic ovary syndrome	0.000608	0.00606	CbGeAlD
Lansoprazole—Pruritus—Metformin—polycystic ovary syndrome	0.000601	0.00498	CcSEcCtD
Lansoprazole—Diarrhoea—Metformin—polycystic ovary syndrome	0.000581	0.00482	CcSEcCtD
Lansoprazole—ABCB1—endometrium—polycystic ovary syndrome	0.000581	0.00579	CbGeAlD
Lansoprazole—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000575	0.00573	CbGeAlD
Lansoprazole—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000566	0.00564	CbGeAlD
Lansoprazole—Dizziness—Metformin—polycystic ovary syndrome	0.000562	0.00465	CcSEcCtD
Lansoprazole—Vomiting—Metformin—polycystic ovary syndrome	0.00054	0.00448	CcSEcCtD
Lansoprazole—Rash—Metformin—polycystic ovary syndrome	0.000535	0.00444	CcSEcCtD
Lansoprazole—ABCB1—uterus—polycystic ovary syndrome	0.000535	0.00533	CbGeAlD
Lansoprazole—Dermatitis—Metformin—polycystic ovary syndrome	0.000535	0.00443	CcSEcCtD
Lansoprazole—Headache—Metformin—polycystic ovary syndrome	0.000532	0.00441	CcSEcCtD
Lansoprazole—ABCB1—pituitary gland—polycystic ovary syndrome	0.000525	0.00524	CbGeAlD
Lansoprazole—ABCB1—adipose tissue—polycystic ovary syndrome	0.000523	0.00521	CbGeAlD
Lansoprazole—Nausea—Metformin—polycystic ovary syndrome	0.000504	0.00418	CcSEcCtD
Lansoprazole—ABCB1—adrenal gland—polycystic ovary syndrome	0.000469	0.00468	CbGeAlD
Lansoprazole—ABCB1—female gonad—polycystic ovary syndrome	0.000438	0.00436	CbGeAlD
Lansoprazole—ABCB1—vagina—polycystic ovary syndrome	0.000435	0.00434	CbGeAlD
Lansoprazole—ABCB1—endocrine gland—polycystic ovary syndrome	0.000407	0.00406	CbGeAlD
Lansoprazole—CYP4A11—Metabolism—MTHFR—polycystic ovary syndrome	2.9e-05	0.000154	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.9e-05	0.000153	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	2.87e-05	0.000152	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NCOR1—polycystic ovary syndrome	2.87e-05	0.000152	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	2.86e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.86e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.86e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	2.85e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	2.84e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.82e-05	0.000149	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.81e-05	0.000149	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.78e-05	0.000147	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.78e-05	0.000147	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.77e-05	0.000147	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.75e-05	0.000145	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.72e-05	0.000144	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—TH—polycystic ovary syndrome	2.72e-05	0.000144	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP1A1—polycystic ovary syndrome	2.72e-05	0.000144	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	2.71e-05	0.000144	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	2.7e-05	0.000143	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.68e-05	0.000142	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.66e-05	0.000141	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.65e-05	0.00014	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SLC2A4—polycystic ovary syndrome	2.65e-05	0.00014	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.64e-05	0.00014	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.62e-05	0.000139	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.6e-05	0.000138	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.57e-05	0.000136	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.55e-05	0.000135	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.54e-05	0.000135	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	2.54e-05	0.000134	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MTHFR—polycystic ovary syndrome	2.54e-05	0.000134	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP19A1—polycystic ovary syndrome	2.49e-05	0.000132	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.48e-05	0.000132	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.48e-05	0.000131	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TH—polycystic ovary syndrome	2.47e-05	0.000131	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	2.47e-05	0.000131	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	2.45e-05	0.00013	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	2.42e-05	0.000128	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	2.42e-05	0.000128	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	2.41e-05	0.000127	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.39e-05	0.000127	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.36e-05	0.000125	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PPARG—polycystic ovary syndrome	2.35e-05	0.000125	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.35e-05	0.000124	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	2.34e-05	0.000124	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.33e-05	0.000124	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.33e-05	0.000123	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	2.33e-05	0.000123	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—POMC—polycystic ovary syndrome	2.32e-05	0.000123	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	2.31e-05	0.000123	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—INS—polycystic ovary syndrome	2.31e-05	0.000122	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	2.28e-05	0.000121	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.27e-05	0.00012	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	2.26e-05	0.00012	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.26e-05	0.00012	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.26e-05	0.00012	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.23e-05	0.000118	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GNAS—polycystic ovary syndrome	2.22e-05	0.000118	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.22e-05	0.000118	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	2.21e-05	0.000117	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.21e-05	0.000117	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	2.19e-05	0.000116	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.19e-05	0.000116	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.18e-05	0.000116	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	2.16e-05	0.000114	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.16e-05	0.000114	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	2.16e-05	0.000114	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NCOR1—polycystic ovary syndrome	2.12e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	2.11e-05	0.000112	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.11e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.1e-05	0.000111	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.09e-05	0.000111	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	2.09e-05	0.000111	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.08e-05	0.00011	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.07e-05	0.00011	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.07e-05	0.000109	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	2.06e-05	0.000109	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.04e-05	0.000108	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.03e-05	0.000108	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	2.03e-05	0.000107	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	2.02e-05	0.000107	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—INS—polycystic ovary syndrome	2.02e-05	0.000107	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.01e-05	0.000107	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	2.01e-05	0.000107	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP1A1—polycystic ovary syndrome	2.01e-05	0.000106	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.99e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.98e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.97e-05	0.000104	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.97e-05	0.000104	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.94e-05	0.000103	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.93e-05	0.000102	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	1.92e-05	0.000102	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.92e-05	0.000102	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.92e-05	0.000102	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.92e-05	0.000102	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.91e-05	0.000101	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.91e-05	0.000101	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.9e-05	0.0001	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.89e-05	0.0001	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.89e-05	9.99e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.88e-05	9.94e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MTHFR—polycystic ovary syndrome	1.87e-05	9.9e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.86e-05	9.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.86e-05	9.87e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	1.82e-05	9.66e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.82e-05	9.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.8e-05	9.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.8e-05	9.51e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.8e-05	9.51e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.77e-05	9.4e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.77e-05	9.37e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.77e-05	9.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.75e-05	9.29e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.75e-05	9.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.73e-05	9.14e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.72e-05	9.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.72e-05	9.08e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.71e-05	9.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.71e-05	9.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.7e-05	9.02e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	1.7e-05	9.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.7e-05	9e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.69e-05	8.96e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.68e-05	8.92e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.68e-05	8.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.67e-05	8.87e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.66e-05	8.81e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.65e-05	8.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.64e-05	8.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.63e-05	8.63e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.63e-05	8.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.61e-05	8.52e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.59e-05	8.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.58e-05	8.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.57e-05	8.33e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.57e-05	8.32e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.57e-05	8.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.56e-05	8.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.55e-05	8.23e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.55e-05	8.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.54e-05	8.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.54e-05	8.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.53e-05	8.11e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.53e-05	8.08e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	1.52e-05	8.03e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.5e-05	7.94e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	1.5e-05	7.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.49e-05	7.91e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—INS—polycystic ovary syndrome	1.49e-05	7.87e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.48e-05	7.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.47e-05	7.77e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.46e-05	7.72e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.46e-05	7.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.45e-05	7.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.44e-05	7.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.4e-05	7.44e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.4e-05	7.41e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	1.38e-05	7.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.37e-05	7.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.37e-05	7.24e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—POMC—polycystic ovary syndrome	1.36e-05	7.2e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—INS—polycystic ovary syndrome	1.35e-05	7.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.34e-05	7.12e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.34e-05	7.08e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.34e-05	7.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.33e-05	7.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.33e-05	7.03e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.33e-05	7.03e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.32e-05	6.98e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.3e-05	6.9e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.3e-05	6.89e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.3e-05	6.87e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.26e-05	6.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.26e-05	6.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.25e-05	6.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.25e-05	6.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.25e-05	6.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.25e-05	6.62e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.23e-05	6.54e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.23e-05	6.49e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.22e-05	6.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.22e-05	6.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	1.19e-05	6.32e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.16e-05	6.13e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.15e-05	6.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.15e-05	6.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.14e-05	6.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	1.13e-05	6e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.12e-05	5.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.12e-05	5.93e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	5.78e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.08e-05	5.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.07e-05	5.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.07e-05	5.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	1.06e-05	5.59e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	5.51e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	5.5e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.04e-05	5.49e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.03e-05	5.45e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.02e-05	5.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.02e-05	5.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.01e-05	5.35e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	9.86e-06	5.22e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	9.8e-06	5.19e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	9.77e-06	5.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	9.72e-06	5.15e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.68e-06	5.12e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.53e-06	5.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	9.42e-06	4.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	9.34e-06	4.94e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	9.29e-06	4.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	9.21e-06	4.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	9.21e-06	4.88e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	9.19e-06	4.87e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INS—polycystic ovary syndrome	9.16e-06	4.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	8.72e-06	4.62e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	8.66e-06	4.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	8.59e-06	4.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	8.56e-06	4.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	8.44e-06	4.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INS—polycystic ovary syndrome	8.39e-06	4.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	8.31e-06	4.4e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.24e-06	4.36e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.02e-06	4.25e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.87e-06	4.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	7.64e-06	4.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.54e-06	3.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	7.53e-06	3.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INS—polycystic ovary syndrome	7.49e-06	3.97e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	7.46e-06	3.95e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—polycystic ovary syndrome	7.35e-06	3.89e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	7.34e-06	3.89e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INS—polycystic ovary syndrome	7.31e-06	3.87e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.03e-06	3.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	6.97e-06	3.69e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.93e-06	3.67e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.89e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.87e-06	3.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INS—polycystic ovary syndrome	6.83e-06	3.62e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.73e-06	3.56e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.41e-06	3.39e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.08e-06	3.22e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	5.95e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	5.87e-06	3.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INS—polycystic ovary syndrome	5.84e-06	3.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.66e-06	3e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.59e-06	2.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.53e-06	2.4e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.51e-06	2.39e-05	CbGpPWpGaD
